Diagnosing IgA Nephropathy: The Role of Immunofluorescence and Immunohistochemistry
What to Know About the No Surprises Act
Advocacy Efforts During the COVID-19 Pandemic
Mary Beth Pfeiffer
PeerThe Pathogenesis of Complement 3 Glomerulopathy (C3G)
The Endothelin System and IgAN: Emerging Evidence
Donald Kohan, MD, PhD
PeerIgAN Insights: The Impact of Proteinuria
Laura H. Mariana, MD, MS,FASN
PeerHelping Ensure Adequate Tissue Sampling Within the MDT
Pre-Testing: Working Together Toward Testing
Interpreting Test Results and Making the Treatment Decision Within the MDT